CURRENT ESSENTIALS of MEDICINE

Total Page:16

File Type:pdf, Size:1020Kb

CURRENT ESSENTIALS of MEDICINE a LANGE medical book CURRENT ESSENTIALS of MEDICINE Fourth Edition Edited by Lawrence M. Tierney, Jr., MD Professor of Medicine University of California, San Francisco Associate Chief of Medical Services Veterans Affairs Medical Center San Francisco, California Sanjay Saint, MD, MPH Associate Chief of Medicine, Ann Arbor VA Medical Center Director, VA/UM Patient Safety Enhancement Program Professor of Internal Medicine, University of Michigan Medical School Ann Arbor, Michigan Mary A. Whooley, MD Professor of Medicine, Epidemiology and Biostatistics University of California, San Francisco Department of Veterans Affairs Medical Center San Francisco, California New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2011, 2005, 2002, 1997 by The McGraw-Hill Companies, Inc. All rights re- served. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-176665-4 MHID: 0-07-176665-0 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-163790-9, MHID: 0-07-163790-7. All trademarks are trademarks of their respective owners. Rather than put a trademark sym- bol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefi t of the trademark owner, with no intention of infringement of the trademark. Where such designations appear in this book, they have been printed with initial caps. McGraw-Hill eBooks are available at special quantity discounts to use as premiums and sales promotions, or for use in corporate training programs. To contact a representative please e-mail us at [email protected]. Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the editors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information con- tained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product informa- tion sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. TERMS OF USE This is a copyrighted work and The McGraw-Hill Companies, Inc. (“McGrawHill”) and its licensors reserve all rights in and to the work. Use of this work is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based upon, transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hill’s prior consent. You may use the work for your own noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work may be terminated if you fail to comply with these terms. THE WORK IS PROVIDED “AS IS.” McGRAW-HILL AND ITS LICENSORS MAKE NO GUARANTEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IM- PLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill and its licensors do not warrant or guarantee that the functions contained in the work will meet your requirements or that its operation will be uninterrupted or error free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of cause, in the work or for any damages resulting therefrom. McGraw-Hill has no responsibility for the content of any information accessed through the work. Under no circumstances shall McGraw-Hill and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar damages that result from the use of or inability to use the work, even if any of them has been advised of the possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever whether such claim or cause arises in contract, tort or otherwise. To Katherine Tierney: a sister whose absolute commitment to her par- ents at the end of their lives provides a model for anyone fortunate enough to know her. Lawrence M. Tierney, Jr. To my father, Prem Saint, and father-in-law, James McCarthy, whose commitment to education will inspire generations. Sanjay Saint In memory of my mother, Mary Aquinas Whooley (1940–2003). Mary A. Whooley This page intentionally left blank Contents Contributors . vii Preface . xi 1. Cardiovascular Diseases . 1 2. Pulmonary Diseases . 37 3. Gastrointestinal Diseases . 66 4. Hepatobiliary Disorders. 92 5. Hematologic Diseases. 109 6. Rheumatologic & Autoimmune Disorders. 147 7. Endocrine Disorders . 178 8. Infectious Diseases . 202 9. Oncologic Diseases . 286 10. Fluid, Acid–Base, and Electrolyte Disorders . 309 11. Genitourinary and Renal Disorders. 325 12. Neurologic Diseases . 350 13. Geriatrics . 372 14. Psychiatric Disorders. 381 15. Dermatologic Disorders. 399 16. Gynecologic, Obstetric, and Breast Disorders . 450 17. Common Surgical Disorders . 468 18. Common Pediatric Disorders. 481 19. Selected Genetic Disorders. 500 20. Common Disorders of the Eye . 509 21. Common Disorders of the Ear, Nose, and Throat . 529 22. Poisoning . 540 Index . 565 Tab Index . Back Cover This page intentionally left blank Contributors Timir Baman, MD Cardiolology Fellow, University of Michigan Medical School, Ann Arbor, Michigan Cardiovascular Diseases Alex Benson, MD Fellow, Department of Pulmonary and Critical Care Medicine, University of Colorado Hospital, Aurora, Colorado Pulmonary Diseases Aaron Berg, MD Clinical Lecturer and Hospitalist, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan Fluid, Acid–Base, and Electrolyte Disorders Jeffrey Critchfield, MD Associate Professor of Clinical Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco School of Medicine, San Francisco, California Rheumatologic & Autoimmune Disorders Vanja Douglas, MD Assistant Clinical Professor, Department of Neurology, University of California, San Francisco, California Neurologic Disorders Rebecca A. Jackson, MD Associate Professor & Chief, Obstetrics, Gynecology and Reproductive Sciences, San Francisco General Hospital, University of California, San Francisco, California Gynecologic, Obstetric, and Breast Disorders viii Contributors Kirsten Neudoerffer Kangelaris, MD Research Fellow, Division of Hospital Medicine, University of California, San Francisco, California Selected Genetic Disorders Helen Kao, MD Assistant Professor, Division of Geriatrics, Department of Medicine, University of California, San Francisco, San Francisco, California Geriatrics Kewchang Lee, MD Associate Clinical Professor of Psychiatry, University of California, San Francisco; Director of Psychiatry Consultation, San Francisco Veterans Affairs Medical Center, San Francisco, California Psychiatric Disorders Joan C. Lo, MD Research Scientist, Division of Research, Kaiser Permanente Northern California; Associate Clinical Professor of Medicine, University of California, San Francisco, Oakland, California Endocrine Disorders Michael P. Lukela, MD Director, Medicine-Pediatrics Residency Program, University of Michigan Medical School, Ann Arbor, Michigan Common Pediatric Disorders Read G. Pierce, MD Chief Resident, Internal Medicine, University of California, San Francisco, San Francisco, California References Jack Resneck, Jr., MD Associate Professor of Dermatology and Health Policy, Department of Dermatology and Phillip R. Lee Institute for Health Policy Studies, University of California, San Francisco School of Medicine, San Francisco, California Dermatologic Disorders Michael Rizen, MD, PhD, and Stephanie T. Phan, MD Eye Clinic of Bellevue, Ltd, P.S., Bellevue, Washington Common Disorders of the Eye Contributors ix Amandeep Shergill, MD Assistant Clinical Professor of Medicine, Division of Gastroenterology, Department of Medicine, San Francisco Veterans Affairs Medical Center & University of California, San Francisco, San Francisco, California Gastrointestinal Diseases Hepatobiliary Disorders Sanjay Shewarkramani, MD Clinical Assistant Professor, Department of Emergency Medicine, Georgetown University
Recommended publications
  • Artificial Intelligence in Health Care: the Hope, the Hype, the Promise, the Peril
    Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril Michael Matheny, Sonoo Thadaney Israni, Mahnoor Ahmed, and Danielle Whicher, Editors WASHINGTON, DC NAM.EDU PREPUBLICATION COPY - Uncorrected Proofs NATIONAL ACADEMY OF MEDICINE • 500 Fifth Street, NW • WASHINGTON, DC 20001 NOTICE: This publication has undergone peer review according to procedures established by the National Academy of Medicine (NAM). Publication by the NAM worthy of public attention, but does not constitute endorsement of conclusions and recommendationssignifies that it is the by productthe NAM. of The a carefully views presented considered in processthis publication and is a contributionare those of individual contributors and do not represent formal consensus positions of the authors’ organizations; the NAM; or the National Academies of Sciences, Engineering, and Medicine. Library of Congress Cataloging-in-Publication Data to Come Copyright 2019 by the National Academy of Sciences. All rights reserved. Printed in the United States of America. Suggested citation: Matheny, M., S. Thadaney Israni, M. Ahmed, and D. Whicher, Editors. 2019. Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril. NAM Special Publication. Washington, DC: National Academy of Medicine. PREPUBLICATION COPY - Uncorrected Proofs “Knowing is not enough; we must apply. Willing is not enough; we must do.” --GOETHE PREPUBLICATION COPY - Uncorrected Proofs ABOUT THE NATIONAL ACADEMY OF MEDICINE The National Academy of Medicine is one of three Academies constituting the Nation- al Academies of Sciences, Engineering, and Medicine (the National Academies). The Na- tional Academies provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions.
    [Show full text]
  • Heterotopic Cervical Pregnancy
    Elmer ress Case Report J Clin Gynecol Obstet. 2015;4(4):307-311 Heterotopic Cervical Pregnancy Mathangi Thangavelua, b, Ravinder Kalkata Abstract tenderness or cervical excitation. Initial hormonal investiga- tions showed BHCG levels were raised to 17,276 IU and ini- We report a rare case of heterotopic cervical pregnancy, which posed tial ultrasound was suggestive of minimal retained products diagnostic challenge. With increasing IVF treatment and raising ce- of conception (Fig. 1). However, a repeat BHCG showed an sarean section rate, there is increasing incidence for non-tubal hetero- increasing trend reaching up to 29,971 IU in 96 h. A repeat topic pregnancy. We have discussed the clinical course of our case, transvaginal scan showed the endometrial cavity had mixed diagnosis and management of cervical pregnancy and some good echoes and multiple cystic spaces, largest measuring 6 × 7 × medical practices to avoid missing atypical presentations of ectopic 8 mm with color flow suggesting a possible molar pregnancy pregnancy. (Fig. 2). Bilateral ovarian cysts were present in both adnexa. Laparoscopy and dilatation and curettage were arranged Keywords: Cervical pregnancy; Heterotopic; Ectopic in view of high BHCG levels and no clear evidence of intrau- terine pregnancy. Laparoscopy was negative for tubal ectopic pregnancy and dilatation and curettage was performed. Post- operatively BHCG levels were monitored to ensure its levels were declining. The levels initially dropped to 2,611 IU from Introduction 29,971 IU in a week after D&C. However, the subsequent BHCG levels doubled to 4,207 IU 2 weeks after D&C. With We report an extremely rare case of spontaneous heterotopic the knowledge of earlier scan findings, raising BHCG levels cervical pregnancy who needed multiple investigations before raised the concern of persistent trophoblastic disease.
    [Show full text]
  • Sports Medicine Examination Outline
    Sports Medicine Examination Content I. ROLE OF THE TEAM PHYSICIAN 1% A. Ethics B. Medical-Legal 1. Physician responsibility 2. Physician liability 3. Preparticipation clearance 4. Return to play 5. Waiver of liability C. Administrative Responsibilities II. BASIC SCIENCE OF SPORTS 16% A. Exercise Physiology 1. Training Response/Physical Conditioning a.Aerobic b. Anaerobic c. Resistance d. Flexibility 2. Environmental a. Heat b.Cold c. Altitude d.Recreational diving (scuba) 3. Muscle a. Contraction b. Lactate kinetics c. Delayed onset muscle soreness d. Fiber types 4. Neuroendocrine 5. Respiratory 6. Circulatory 7. Special populations a. Children b. Elderly c. Athletes with chronic disease d. Disabled athletes B. Anatomy 1. Head/Neck a.Bone b. Soft tissue c. Innervation d. Vascular 2. Chest/Abdomen a.Bone b. Soft tissue c. Innervation d. Vascular 3. Back a.Bone b. Soft tissue c. Innervation 1 d. Vascular 4. Shoulder/Upper arm a. Bone b. Soft tissue c. Innervation d. Vascular 5. Elbow/Forearm a. Bone b. Soft tissue c. Innervation d. Vascular 6. Hand/Wrist a. Bone b. Soft tissue c. Innervation d. Vascular 7. Hip/Pelvis/Thigh a. Bone b. Soft tissue c. Innervation d. Vascular 8. Knee a. Bone b. Soft tissue c. Innervation d. Vascular 9. Lower Leg/Foot/Ankle a. Bone b. Soft tissue c. Innervation d. Vascular 10. Immature Skeleton a. Physes b. Apophyses C. Biomechanics 1. Throwing/Overhead activities 2. Swimming 3. Gait/Running 4. Cycling 5. Jumping activities 6. Joint kinematics D. Pharmacology 1. Therapeutic Drugs a. Analgesics b. Antibiotics c. Antidiabetic agents d. Antihypertensives e.
    [Show full text]
  • Organ Transplant Manual
    Congratulations! ystem lth S Hea sity iver Un 013 y, 2 Ma t© igh pyr Co Dear Patient: Congratulations! You have been given the gift of life! Receiving a transplant is a marvelous gift and the Transplant Team members will meet with you Transplant Team is here to assist you in taking care during your hospitalization to help you learn this of that gift. information. Here are some suggestions that may help you learn: Transplant Team members include the surgeons, medicine physicians, nurses, discharge coordinator, • Listen to the Transplant Team and ask them questions patient educator, dietitian, transplant pharmacists about things you don’t understand. and social workers. • Study every day. This manual is designed to help you care for yourself • Ask a family member or friend to study with you. following your transplant. As you read the following We want you to be able to return to your home and information, feel free to ask questions of your family in the best possible health to enjoy an active Transplant Team. and productive life. Understanding the information in this manual You must take your prescribed medications, follow is important. your diet, exercise, and monitor yourself for signs and symptoms of infection and rejection. By working as a team, you will achieve the best possible outcome from your transplant. Tim Nevil Kidney Recipient, 2001 Tania S. Gonzales José David Aguirre Liver Transplant Recipient, 2002 Liver Transplant Recipient, 2001 Table of Contents Organ Transplant Manual Contacting the Transplant Team When to Call ...........................................3
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Successful Treatment of Cervical Ectopic Pregnancy with Multi Dose
    Case Report iMedPub Journals Gynaecology & Obstetrics Case report 2020 www.imedpub.com ISSN 2471-8165 Vol.6 No.2:14 DOI: 10.36648/2471-8165.6.2.94 Successful Treatment of Cervical Ectopic Iqbal S1*, Iqbal J2, Nowshad N1 and Pregnancy with Multi Dose Methotrexate Mohammad K1 Therapy 1 Department of Obstetrics and Gynecology, Latifa Hospital, Dubai Health Authority Jaddaf, Dubai, UAE 2 Department of Medical Education, Dubai Abstract Medical University, Dubai, UAE Cervical ectopic pregnancies account for less than 1% of all pregnancies. Earlier, it was associated with significant hemorrhage and was treated presumptively with hysterectomy. With the advent of enhanced ultrasound techniques, early *Corresponding author: Iqbal S detection of these pregnancies has led to the development of more effective conservative management. We present a case of a cervical ectopic pregnancy successfully treated with multi-dose Methotrexate therapy. [email protected] A 37-year-old lady, G3P0+2, pregnant for 9 weeks and 4 days, presented with bleeding per vagina, mild lower abdomen and back pain. Serum Beta-hCG done Department of Obstetrics and Gynecology, 5 days ago was 950 mIU/mL. She was diagnosed as ectopic cervical pregnancy Latifa Hospital, Dubai Health Authority by clinical examination which was confirmed by transvaginal ultrasonography Jaddaf, Dubai, UAE. and subsequently managed by Methotrexate (MTX) Hybrid double dose protocol. Due to rising Beta-hCG and continuous bleeding, it was modified to Multi dose Tel: 971569400124 Methotrexate Therapy. Thereafter, the patient was asymptomatic with falling beta-hCG and she was put on a weekly follow up in the clinic. Keywords: Ectopic pregnancy; Cervical pregnancy; Methrotrexate; Gynaecology Citation: Iqbal S, Iqbal J, Nowshad N, Mohammad K (2020) Successful Treatment of Cervical Ectopic Pregnancy with Multi Received: March 31, 2020; Accepted: May 02, 2020; Published: May 06, 2020 Dose Methotrexate Therapy.
    [Show full text]
  • Malassezia Furfur Folliculitis in Cancer Patients. the Need for Interaction Of
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 5 Copyright © 1993, Institute for Clinical Science, Inc. Malassezia furfur Folliculitis in Cancer Patients The Need for Interaction of Microbiologist, Surgical Pathologist, and Clinician in Facilitating Identification by the Clinical Microbiology Laboratory* RAMON L. SANDIN, M.D., M.S.,f TZANN-TARN FANG, M.D.,* JOHN W. HIEMENZ, M.D.,t JOHN N. GREENE, M.D.,§ LINA CARD, M.T. (ASCP),t ALEXANDRA KALIK, M.D.,t and JENO E. SZAKACS, M.D.t Departments of Pathology, f Bone Marrow Transplant Service,t and Infectious Diseases,§ H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612-9497 ABSTRACT Malassezia furfur (MF) is a lipophilic yeast which can be found as a member of the indigenous microbiota of human skin. In immunocompro­ mised transplant patients, MF can cause a distinctive folliculitis which is a clinical look-alike to Candida folliculitis, the latter of more potentially devastating significance. Recovery of MF in culture is dependent upon the addition to culture media of an exogenous source of fatty acids, such as olive oil. The addition of an extra Sabourauds plate with an olive oil overlay to the routine set of media used to inoculate all skin biopsy specimens in order to detect MF is labor-intensive and not cost-effective. Thus, MF may not be isolated in cases of MF folliculitis unless the clinical microbiology laboratory is put on alert by the clinical suspicions of the attending physi­ cian, or by histopathologic findings suggestive of folliculitis revealed by review of surgical pathology slides.
    [Show full text]
  • Genital Dermatology
    GENITAL DERMATOLOGY BARRY D. GOLDMAN, M.D. 150 Broadway, Suite 1110 NEW YORK, NY 10038 E-MAIL [email protected] INTRODUCTION Genital dermatology encompasses a wide variety of lesions and skin rashes that affect the genital area. Some are found only on the genitals while other usually occur elsewhere and may take on an atypical appearance on the genitals. The genitals are covered by thin skin that is usually moist, hence the dry scaliness associated with skin rashes on other parts of the body may not be present. In addition, genital skin may be more sensitive to cleansers and medications than elsewhere, emphasizing the necessity of taking a good history. The physical examination often requires a thorough skin evaluation to determine the presence or lack of similar lesions on the body which may aid diagnosis. Discussion of genital dermatology can be divided according to morphology or location. This article divides disease entities according to etiology. The clinician must determine whether a genital eruption is related to a sexually transmitted disease, a dermatoses limited to the genitals, or part of a widespread eruption. SEXUALLY TRANSMITTED INFECTIONS AFFECTING THE GENITAL SKIN Genital warts (condyloma) have become widespread. The human papillomavirus (HPV) which causes genital warts can be found on the genitals in at least 10-15% of the population. One study of college students found a prevalence of 44% using polymerase chain reactions on cervical lavages at some point during their enrollment. Most of these infection spontaneously resolved. Only a minority of patients with HPV develop genital warts. Most genital warts are associated with low risk HPV types 6 and 11 which rarely cause cervical cancer.
    [Show full text]
  • Electrolyte and Acid-Base
    Special Feature American Society of Nephrology Quiz and Questionnaire 2013: Electrolyte and Acid-Base Biff F. Palmer,* Mark A. Perazella,† and Michael J. Choi‡ Abstract The Nephrology Quiz and Questionnaire (NQ&Q) remains an extremely popular session for attendees of the annual meeting of the American Society of Nephrology. As in past years, the conference hall was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, *Department of Internal Medicine, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories University of Texas along with single-best-answer questions were prepared by a panel of experts. Prior to the meeting, program Southwestern Medical directors of United States nephrology training programs answered questions through an Internet-based ques- Center, Dallas, Texas; † tionnaire. A new addition to the NQ&Q was participation in the questionnaire by nephrology fellows. To review Department of Internal Medicine, the process, members of the audience test their knowledge and judgment on a series of case-oriented questions Yale University School prepared and discussed by experts. Their answers are compared in real time using audience response devices with of Medicine, New the answers of nephrology fellows and training program directors. The correct and incorrect answers are then Haven, Connecticut; ‡ briefly discussed after the audience responses, and the results of the questionnaire are displayed. This article and Division of recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases Nephrology, Department of and expert discussions. Medicine, Johns Clin J Am Soc Nephrol 9: 1132–1137, 2014.
    [Show full text]
  • Phase 4 Medicine Intended Learning Outcomes (Ilos)
    Phase 4 Medicine Intended Learning Outcomes (ILOs) This Phase 4 document outlines the listed ILOs for Medicine. This will be examined in the Year 4 and Year 5 summative written examinations. It is important that we impress upon you the limitation of any ILOs in their application to a vocational professional course such as medicine. ILOs may be useful in providing a ‘shopping list’ of conditions that you will be expected to describe and anticipate. The depth and extent of your knowledge of each condition will be a joint function of the condition’s frequency and its gravity. Please use the ILOs to make sure you are familiar with the common and important presentations and conditions. The list does not comprise of the entire coda for successful medical practice but will provide you with a solid platform from which to build upon. More detailed explanations and outlines will be available in the standard textbooks. Any elucidation or expansion can be obtained there. Even more important is the point that ILOs will point you in the correct direction to pass our written exam, but that this is only part of the story. ILOs will point you in the correct direction to pass our written exam, but that this is only part of the story. Final exams function as ‘objective proof’ for the general public that you have enough knowledge to function as a doctor. As you will see during your time on the wards, however, being a doctor requires much more than knowledge; as well as being able to imitate and build on the activities you witness in your clinical placements, it is imperative that you acquire skills, behaviours, specific attitudes, and commitment to your patients’ well being.
    [Show full text]
  • Alpha Thalassemia
    Alpha Thalassemia Alpha thalassemia is a genetic disorder called a hemoglobinopathy, or an inherited type of anemia. People who have alpha thalassemia make red blood cells that are not able to carry oxygen as well throughout the body, which can lead to anemia. This chronic anemia can include pale skin, fatigue, and weakness. In more severe cases, people with alpha thalassemia can also develop jaundice (yellowing of the eyes and skin), heart defects, and an enlarged liver and spleen (called hepatosplenomegaly). Alpha thalassemia is more common in people of African, Southeast Asian, Chinese, Middle Eastern, and Mediterranean ancestries. Causes We have over 20,000 different genes in the body. These genes are like instruction manuals for how to build a protein, and each protein has an important function that helps to keep our body working how it should. The HBA1 and HBA2 genes make a protein called alpha-globin. Two of the alpha-globin proteins combine with two other proteins called beta-globins (which are made by the HBB gene) to make a normal red blood cell. Most people have four copies of the genes that make the alpha-globin protein: two copies of the HBA1 gene (one from each parent), and two copies of the HBA2 gene (one from each parent). Having all four copies of these genes is symbolized by writing αα/αα. Whether or not someone has alpha thalassemia depends on how many working copies of the alpha- globin gene they have (if someone has a missing or nonworking alpha-globin gene, it is most frequently caused by a deletion): Silent alpha thalassemia carrier (also referred to as -α/αα): When there is one missing alpha-globin gene.
    [Show full text]
  • An Analysis of Psoriasis Skin Images
    International Journal of Inventive Engineering and Sciences (IJIES) ISSN: 2319–9598, Volume-2 Issue-12, November 2014 An Analysis of Psoriasis Skin Images Ashwini C. Bolkote, M.B. Tadwalkar Abstract— In this study a skin disease diagnosis system was Furthermore the evaluation of different use interstitial disease developed and tested. The system was used for diagnosis of is one of the most difficult psoriases skin disease. Present study relied on both skin color and problems in diagnostic radiology. texture features (features derives from the GLCM) to give a better A thoracic CT scan generates about 240 section images for and more efficient recognition accuracy of skin diseases. In this study feed forward neural networks is used to classify input radiologists to interpret (Acharya and Ray, 2005) images to be psoriases infected or non psoriasis infected. Chest radiography-computerized automated analysis of heart sizes; an automated method is being developed for Index Terms— Skin recognition, skin texture, computer aided determining a number of parameters related to the size and disease diagnosis, texture analysis, neural networks, Psoriasis. shape of the heart and of the lung in chest radiographs (60 chest radio- graphs were generally acceptable to radiologist I. INTRODUCTION for the estimation of the size and area of the heart project. With advance of medical imaging technologies (including Colon cancer-colon cancer is the second leading cause of instrumentation, computer and algorithm), the acquired data cancer deaths for men and woman in the USA. Most colon information is getting so rich toward beyond the humans cancers can be prevented if recursor colonic polyps are capability of visual recognition and efficient use for clinical detected and removed.
    [Show full text]